Agency Information Collection Activities: Proposed Collection: Comment Request, 63841-63842 [2012-25587]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 77, No. 201 / Wednesday, October 17, 2012 / Notices
portion of the meeting will be closed to
the public.
Name of Committee: Cellular, Tissue
and Gene Therapies Advisory
Committee.
General Function of the Committee:
To provide advice and
recommendations to the Agency on
FDA’s regulatory issues.
DATES: Date and Time: The
teleconference meeting will be held on
November 29, 2012 from 1 p.m. to 5
p.m., Eastern Time.
Location: National Institutes of Health
(NIH), Building 29A, Conference Room
1A09, 9000 Rockville Pike, Bethesda,
MD 20892. The public is welcome to
attend the meeting at the specified
location where a speakerphone will be
provided. Public participation in the
meeting is limited to the use of the
speakerphone in the conference room.
Important information about
transportation and directions to the NIH
campus, parking, and security
procedures is available on the internet
at https://www.nih.gov/about/visitor/
index.htm. (FDA has verified the Web
site address, but FDA is not responsible
for any subsequent changes to the Web
site after this document publishes in the
Federal Register.) Visitors must show
two forms of identification, one of
which must be a government-issued
photo identification such as a Federal
employee badge, driver’s license,
passport, green card, etc. Detailed
information about security procedures is
located at https://www.nih.gov/about/
visitorsecurity.htm. Due to the limited
available parking, visitors are
encouraged to use public transportation.
Contact Person: Gail Dapolito or
Sheryl Clark, Center for Biologics
Evaluation and Research (HFM–71),
Food and Drug Administration, 1401
Rockville Pike, Rockville MD 20852,
301–827–0314, or FDA Advisory
Committee Information Line, 1–800–
741–8138 (301–443–0572 in the
Washington, DC area). A notice in the
Federal Register about last minute
modifications that impact a previously
announced advisory committee meeting
cannot always be published quickly
enough to provide timely notice.
Therefore, you should always check the
Agency’s Web site at https://
www.fda.gov/AdvisoryCommittees/
default.htm and scroll down to the
appropriate advisory committee meeting
link, or call the advisory committee
information line to learn about possible
modifications before coming to the
meeting.
Agenda: On November 29, 2012 the
committee will meet in open session to
hear updates of research programs in the
VerDate Mar<15>2010
18:49 Oct 16, 2012
Jkt 229001
Gene Transfer and Immunogenicity
Branch, Office of Cellular, Tissue and
Gene Therapies, Center for Biologics
Evaluation and Research, and the
Laboratory of Immunology, Office of
Biotechnology Products, Center for Drug
Evaluation and Research, FDA.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee link.
Procedure: On November 29, 2012,
from 1 p.m. to 4 p.m. (Eastern Time) the
meeting is open to the public. Interested
persons may present data, information,
or views, orally or in writing, on issues
pending before the committee. Written
submissions may be made to the contact
person on or before November 21, 2012.
Oral presentations from the public will
be scheduled between approximately 3
p.m. and 4 p.m. Those individuals
interested in making formal oral
presentations should notify the contact
person and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before
November 14, 2012. Time allotted for
each presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by November 15, 2012.
Closed Committee Deliberations: On
November 29, 2012, from 4 p.m. to 5
p.m., the meeting will be closed to
permit discussion where disclosure
would constitute a clearly unwarranted
invasion of personal privacy (5 U.S.C.
552b(c)(6)). The committee will discuss
reports of intramural research programs
and make recommendations regarding
personnel staffing decisions.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
63841
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Gail Dapolito
at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/Advisory
Committees/AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings. Notice of this
meeting is given under the Federal
Advisory Committee Act (5 U.S.C. app.
2).
Dated: October 9, 2012.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2012–25482 Filed 10–16–12; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection:
Comment Request
In compliance with the requirement
for opportunity for public comment on
proposed data collection projects
(section 3506(c)(2)(A) of Title 44, United
States Code, as amended by the
Paperwork Reduction Act of 1995, Pub.
L. 104–13), the Health Resources and
Services Administration (HRSA)
publishes periodic summaries of
proposed projects being developed for
submission to the Office of Management
and Budget (OMB) under the Paperwork
Reduction Act of 1995. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and draft instruments, email
paperwork@hrsa.gov or call the HRSA
Reports Clearance Officer at (301) 443–
1984.
Comments are invited on: (a) The
proposed collection of information for
the proper performance of the functions
of the agency; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology.
E:\FR\FM\17OCN1.SGM
17OCN1
63842
Federal Register / Vol. 77, No. 201 / Wednesday, October 17, 2012 / Notices
Proposed Project: National Health
Service Corps Scholar Travel
Worksheet (OMB No. 0915–0278)—
Revision
Clinicians participating in the HRSA
National Health Service Corps (NHSC)
Scholarship Program use the online
Travel Request Worksheet to request
travel funds from the federal
government for pre-employment
interviews at sites on the NHSC’s Job
Opportunities List.
The travel approval process is
initiated when a scholar notifies the
NHSC of an impending interview at one
or more NHSC-approved practice sites.
The Travel Request Worksheet is also
used to process an NHSC scholar’s
request to be reimbursed for moving
expenses after he/she has successfully
been matched to an approved practice
Number of
respondents
Instrument
Responses
per
respondent
site. Upon receipt of the Travel Request
Worksheet, the NHSC will review and
approve or disapprove the request and
promptly notify the scholar and the
NHSC logistics contractor regarding
travel arrangements and authorization of
the funding for the site visit or
relocation.
The annual estimate of burden is as
follows:
Total
responses
Hours per
response
Total burden
hours
Scholar Travel Request Worksheet .....................................
180
2
360
.0667
24
Total ..............................................................................
180
2
360
.0667
24
Email comments to
paperwork@hrsa.gov or mail the HRSA
Reports Clearance Officer, Room 10–29,
Parklawn Building, 5600 Fishers Lane,
Rockville, MD 20857. Written comments
should be received within 60 days of
this notice.
Dated: October 11, 2012.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2012–25587 Filed 10–16–12; 8:45 am]
BILLING CODE 4165–15–P
Place: Intramural Research Program,
National Institute on Drug Abuse, NIH, Johns
Hopkins Bayview Campus, Baltimore, MD
21223.
Contact Person: Joshua Kysiak, Program
Specialist, Biomedical Research Center,
Intramural Research Program, National
Institute on Drug Abuse, NIH, DHHS, 251
Bayview Boulevard, Baltimore, MD 21224,
443–740–2465, kysiakjo@nida.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: October 11, 2012.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2012–25449 Filed 10–16–12; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
mstockstill on DSK4VPTVN1PROD with NOTICES
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, NIDA.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute on Drug Abuse,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIDA.
Date: November 15, 2012.
Closed: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
VerDate Mar<15>2010
20:03 Oct 16, 2012
Jkt 229001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: AIDS and Related
Research Integrated Review Group; HIV/
AIDS Vaccines Study Section.
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Date: November 9, 2012
Open: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Mary Clare Walker, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5208,
MSC 7852, Bethesda, MD 20892, (301) 435–
1165, walkermc@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR10–021:
AIDS-Science Track Award for Research
Transition (R03).
Date: November 9, 2012.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street,
NW., Washington, DC 20036.
Contact Person: Jose H. Guerrier, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–435–
1137, guerriej@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Channels, Transporters and
Neurotransmission.
Date: November 14, 2012.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Geoffrey G. Schofield,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040–A,
MSC 7850, Bethesda, MD 20892, 301–435–
1235, geoffreys@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Physiology and Pathobiology of
Musculoskeletal, Oral, and Skin Systems.
Date: November 15, 2012.
Time: 8:00 a.m. to 5:00 p.m.
E:\FR\FM\17OCN1.SGM
17OCN1
]]>Agencies
[Federal Register Volume 77, Number 201 (Wednesday, October 17, 2012)]
[Notices]
[Pages 63841-63842]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-25587]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Proposed Collection:
Comment Request
In compliance with the requirement for opportunity for public
comment on proposed data collection projects (section 3506(c)(2)(A) of
Title 44, United States Code, as amended by the Paperwork Reduction Act
of 1995, Pub. L. 104-13), the Health Resources and Services
Administration (HRSA) publishes periodic summaries of proposed projects
being developed for submission to the Office of Management and Budget
(OMB) under the Paperwork Reduction Act of 1995. To request more
information on the proposed project or to obtain a copy of the data
collection plans and draft instruments, email paperwork@hrsa.gov or
call the HRSA Reports Clearance Officer at (301) 443-1984.
Comments are invited on: (a) The proposed collection of information
for the proper performance of the functions of the agency; (b) the
accuracy of the agency's estimate of the burden of the proposed
collection of information; (c) ways to enhance the quality, utility,
and clarity of the information to be collected; and (d) ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
[[Page 63842]]
Proposed Project: National Health Service Corps Scholar Travel
Worksheet (OMB No. 0915-0278)--Revision
Clinicians participating in the HRSA National Health Service Corps
(NHSC) Scholarship Program use the online Travel Request Worksheet to
request travel funds from the federal government for pre-employment
interviews at sites on the NHSC's Job Opportunities List.
The travel approval process is initiated when a scholar notifies
the NHSC of an impending interview at one or more NHSC-approved
practice sites. The Travel Request Worksheet is also used to process an
NHSC scholar's request to be reimbursed for moving expenses after he/
she has successfully been matched to an approved practice site. Upon
receipt of the Travel Request Worksheet, the NHSC will review and
approve or disapprove the request and promptly notify the scholar and
the NHSC logistics contractor regarding travel arrangements and
authorization of the funding for the site visit or relocation.
The annual estimate of burden is as follows:
----------------------------------------------------------------------------------------------------------------
Number of Responses per Total Hours per Total burden
Instrument respondents respondent responses response hours
----------------------------------------------------------------------------------------------------------------
Scholar Travel Request Worksheet 180 2 360 .0667 24
-------------------------------------------------------------------------------
Total....................... 180 2 360 .0667 24
----------------------------------------------------------------------------------------------------------------
Email comments to paperwork@hrsa.gov or mail the HRSA Reports
Clearance Officer, Room 10-29, Parklawn Building, 5600 Fishers Lane,
Rockville, MD 20857. Written comments should be received within 60 days
of this notice.
Dated: October 11, 2012.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2012-25587 Filed 10-16-12; 8:45 am]
BILLING CODE 4165-15-P
